These early results show a significant increase of CCL8, CCL14, CCL19 and CCL22 in RA compared to non-RA synovium and following further validation may suggest that EC presentation of these chemokines could also play a role in the recruitment of inflammatory cells in RA. This evidence concerns the gene CCL8 and rheumatoid arthritis.